The Nancy E. and Peter C. Meinig School of Biomedical Engineering at Cornell University is building research and educational programs around a vision that a quantitative understanding of the human body can be used as a foundation for the rational design of therapies, molecules, devices, and diagnostic procedures to improve human health.
The primary mission of the Meinig School of Biomedical Engineering is to educate students to understand the human body as an integrated system and the mechanisms of disease through quantitative engineering analysis, and to use that understanding to design better therapeutic strategies, devices, and diagnostics to improve human health.
Bachelor of Science in Biomedical Engineering
The mission of the B.S. program in biomedical engineering (BME) is to train students in the practice of design, fabrication, and analysis of biomedical systems, devices, diagnostics, and therapeutics. Specifically, Cornell's vision of biomedical engineering centers around a quantitative approach to understanding biology across length and time scales, with a focus on issues related to human health.
Doctor of Philosophy in Biomedical Engineering
Biomedical Engineering at Cornell University focuses on interdisciplinary research to achieve a quantitative understanding of human biology at all spatial and temporal scales with the goal of improving human health.
Masters of Engineering in Biomedical Engineering
Engineers who understand biology and who can apply their knowledge and skills to improve human health are increasingly in demand. A professional degree in biomedical engineering will prepare students to fill this increasingly critical need.
Join us in August!
Join us Friday August 10, 2018 for a daylong symposium, "Our Microbes, Our Global Health," on how microbiome research and therapeutics can address global health issues. Organized by the Meinig School faculty Ilana Brito. For more details and to register, visit the event website, www.globalmicrobiomes.org.
Did you know?
UltrOZ, a wearable therapeutic ultrasound system for horses, provides up to six hours of unsupervised ultrasound therapy to reduce inflammation and promote healing. The technology grew out of work done by Cornell alum, George K. Lewis, (BME, M.S. 2008, Ph.D., 2012) who co-founded the company.